Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifampicin effects on sublingual and intravenous buprenorphine in healthy volunteers
2012-002871-32Phase 4Completed
- Sponsor
- Turku University Hospital
- Start
- Jul 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of buprenorphine and rifampicin, sponsored by Turku University Hospital. Primary endpoint: Buprenorphine venous plasma concentration-time profile. Started Jul 2012; status: completed.
02
Drugs
buprenorphinerifampicin
Beyond the preview
Go deeper on 2012-002871-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002871-32.